Back
Sage Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
SAGE
Sage Therapeutics
Last Price:
$8.62
Seasonality Move:
6.64%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.06 | Buy |
20-day SMA: | 7.68 | Buy |
50-day SMA: | 7.34 | Buy |
200-day SMA: | 7.85 | Buy |
8-day EMA: | 8.09 | Buy |
20-day EMA: | 7.78 | Buy |
50-day EMA: | 7.33 | Buy |
200-day EMA: | 9.21 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 72.27 | Buy |
Chaikin Money Flow: | 1635708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.18 - 7.98) | Buy |
Bollinger Bands (100): | (5.55 - 7.57) | Buy |
Sage Therapeutics Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 8.53 while SAGE 8-day simple moving average is 8.06, which is a Buy signal.
-
The stock price of SAGE is 8.53 while Sage Therapeutics 20-day SMA is 7.68, which makes it a Buy.
-
Sage Therapeutics 50-day simple moving average is 7.34 while SAGE share price is 8.53, making it a Buy technically.
-
SAGE stock price is 8.53 and Sage Therapeutics 200-day simple moving average is 7.85, creating a Buy signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
47
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $8.53. The Score for SAGE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
524.4M
Price in USD:
8.53
Share Volume:
1.8M
Sage Therapeutics 52-Week Range
52-Week High:
19.34
52-Week Low:
4.62
Sell
47
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 8.53 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 8.53 while SAGE 8-day exponential moving average is 8.09, which is a Buy signal.
-
The stock price of SAGE is 8.53 while Sage Therapeutics 20-day EMA is 7.78, which makes it a Buy.
-
Sage Therapeutics 50-day exponential moving average is 7.33 while SAGE share price is 8.53, making it a Buy technically.
-
SAGE stock price is 8.53 and Sage Therapeutics 200-day simple moving average is 9.21, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.42 per share, an increase this year of $2.66 per share, and an increase next year of $1.19 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Sage Therapeutics is a Buy
-
Sage Therapeutics Relative Strength Index (RSI) is 72.27, which suggest Sage Therapeutics is overbought
-
The Bollinger Bands (25) for Sage Therapeutics is (7.18 - 7.98), which suggest Sage Therapeutics is a Buy
-
The Bollinger Bands (100) for Sage Therapeutics is (5.55 - 7.57), which suggest Sage Therapeutics is a Buy
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.